The gene editing technology CRISPR-Cas9 might be prompting major ethical questions about its use in altering human intelligence and appearance, but biotech startups are now pushing it forward as a way to make better cancer therapies.
In the second deal of... Read more »
[Updated 5/27/15 12:45 pm. See below.] Bluebird Bio is expanding its technology reach with antibodies from Five Prime Therapeutics as part of its plan to develop next-generation cancer therapies.
Cambridge, MA-based Bluebird (NASDAQ: BLUE) specializes in gene therapy,... Read more »
Two recent happenings prompted this column. First, Orexigen Therapeutics drew fire from, well, nearly everyone earlier this month for an improper release of data related to its weight-loss drug Contrave. The second happening is Memorial Day weekend.
I’m assuming you, like... Read more »
In addition to significant fundraising news from iSpot.tv, Glowforge, and Ignition Partners, we’re tracking the winners of the University of Washington’s business plan competition, Seattle Angel Conference, and more.
First, here’s a recap of Xconomy Seattle stories this week, followed by... Read more »
Out west this week, the news flow was breezy. There were a sprinkling of diagnostics showers led by Illumina, which is in a patent fight with a Roche subsidiary, and Veracyte, which presented promising data for its lung test. It also... Read more »
The headline on venture capital firm Ignition Partners‘ pitch deck to investors in its new $200 million fund was “No Change.”
Ignition, based in based in Bellevue, WA, and Palo Alto, CA, has good reason to stay the course. In announcing... Read more »
Synlogic has already attracted some $35 million from investors on both coasts, including the Bill & Melinda Gates Foundation, to pursue a science fiction-like idea to make customized disease-killing bacteria. Now, the Cambridge, MA-based startup has brought in a well-known former... Read more »
The University of Washington’s computer science program granted 30 percent of its undergraduate degrees last year to women, a mark that earned it recognition from the National Center for Women and Information Technology (NCWIT).
The UW received the grand prize in... Read more »
If there’s one Seattle-area startup making something I really want, Glowforge is it.
The company just raised $9 million from Foundry Group, True Ventures, and leaders of 3D-printing company MakerBot to build a consumer-grade “3D laser printer”—more commonly known as a... Read more »
Taking advantage of a healthy bounce on Wall Street, San Diego’s Fate Therapeutics (NASDAQ: FATE) said Monday it plans to sell 6 million shares of its common stock through a secondary public offering.
All shares of common stock to be... Read more »